AMRX

SEC source: 0001723128-25-000048 · wk-form4_1755117489.xml · nonDerivative · entry 1

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 256,670

F1 · price: The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.05 to $9.07 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

SEC source: 0001628280-25-032108 · wk-form4_1750277496.xml · nonDerivative · entry 1

Patel Gautam · CIK 0001738054 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,609,144

F1 · price: These transactions occurred automatically pursuant to a plan adopted by the Reporting Person on August 15, 2024, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.05 per share, inclusive. The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

SEC source: 0001628280-25-030958 · wk-form4_1749759347.xml · nonDerivative · entry 1

Patel Gautam · CIK 0001738054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,704,050

F1 · price: The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.05 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-026513 · wk-form4_1747685776.xml · nonDerivative · entry 1

Shah Nikita · CIK 0001738061 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 388,929

F1 · price: The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.48 to $7.63 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-025140 · wk-form4_1747168964.xml · nonDerivative · entry 1

Kiely John · CIK 0001781149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,433

F1 · price: The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.49 to $7.67 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-25-023985 · wk-form4_1746744829.xml · derivative · entry 3

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,747

Underlying: Class A Common Stock · 48,747 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

SEC source: 0001628280-25-023998 · wk-form4_1746745819.xml · derivative · entry 3

Autor Deborah M. · CIK 0001884671 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,819

Underlying: Class A Common Stock · 34,819 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

SEC source: 0001628280-25-023989 · wk-form4_1746745065.xml · derivative · entry 3

George Jeffrey P. · CIK 0001796789 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,819

Underlying: Class A Common Stock · 34,819 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

SEC source: 0001628280-25-023991 · wk-form4_1746745306.xml · derivative · entry 3

Kiely John · CIK 0001781149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,819

Underlying: Class A Common Stock · 34,819 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

SEC source: 0001628280-25-023987 · wk-form4_1746744960.xml · derivative · entry 3

Alva Emily Peterson · CIK 0001738422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,819

Underlying: Class A Common Stock · 34,819 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

SEC source: 0001628280-25-024004 · wk-form4_1746748442.xml · derivative · entry 4

BUCHI J KEVIN · CIK 0001209726 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,819

Underlying: Class A Common Stock · 34,819 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

SEC source: 0001628280-25-024000 · wk-form4_1746747275.xml · derivative · entry 3

Yanai Shlomo · CIK 0001562645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,819

Underlying: Class A Common Stock · 34,819 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

SEC source: 0001628280-25-023993 · wk-form4_1746745423.xml · derivative · entry 3

Nark Ted C · CIK 0001316851 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,819

Underlying: Class A Common Stock · 34,819 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

SEC source: 0001628280-25-023966 · wk-form4_1746742630.xml · derivative · entry 3

Patel Gautam · CIK 0001738054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,819

Underlying: Class A Common Stock · 34,819 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

F3 · derivative.expiration_date: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

SEC source: 0001628280-25-022719 · wk-form4_1746563381.xml · nonDerivative · entry 2

Patel Gautam · CIK 0001738054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,720,218

F1 · price: These transactions occurred automatically pursuant to a plan adopted by the Reporting Person on August 15, 2024, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.01 per share, inclusive. The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

SEC source: 0001628280-25-023985 · wk-form4_1746744829.xml · derivative · entry 2

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 56,361 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: On May 2, 2024, the reporting person was granted 56,361 restricted stock units vesting on May 5, 2025.

F2 · derivative.expiration_date: On May 2, 2024, the reporting person was granted 56,361 restricted stock units vesting on May 5, 2025.

SEC source: 0001628280-25-023985 · wk-form4_1746744829.xml · nonDerivative · entry 1

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 784,053

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001628280-25-023998 · wk-form4_1746745819.xml · derivative · entry 2

Autor Deborah M. · CIK 0001884671 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 40,258 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

F2 · derivative.expiration_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

SEC source: 0001628280-25-023998 · wk-form4_1746745819.xml · nonDerivative · entry 1

Autor Deborah M. · CIK 0001884671 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001628280-25-023989 · wk-form4_1746745065.xml · derivative · entry 2

George Jeffrey P. · CIK 0001796789 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 40,258 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

F2 · derivative.expiration_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

SEC source: 0001628280-25-023989 · wk-form4_1746745065.xml · nonDerivative · entry 1

George Jeffrey P. · CIK 0001796789 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 309,795

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001628280-25-023991 · wk-form4_1746745306.xml · derivative · entry 2

Kiely John · CIK 0001781149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 40,258 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

F2 · derivative.expiration_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

SEC source: 0001628280-25-023991 · wk-form4_1746745306.xml · nonDerivative · entry 1

Kiely John · CIK 0001781149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 307,433

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001628280-25-023987 · wk-form4_1746744960.xml · derivative · entry 2

Alva Emily Peterson · CIK 0001738422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 40,258 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

F2 · derivative.expiration_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

SEC source: 0001628280-25-023987 · wk-form4_1746744960.xml · nonDerivative · entry 1

Alva Emily Peterson · CIK 0001738422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 211,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001628280-25-024004 · wk-form4_1746748442.xml · derivative · entry 3

BUCHI J KEVIN · CIK 0001209726 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 40,258 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

F2 · derivative.expiration_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

SEC source: 0001628280-25-024004 · wk-form4_1746748442.xml · nonDerivative · entry 1

BUCHI J KEVIN · CIK 0001209726 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,258

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001628280-25-024000 · wk-form4_1746747275.xml · derivative · entry 2

Yanai Shlomo · CIK 0001562645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 40,258 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

F2 · derivative.expiration_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

SEC source: 0001628280-25-024000 · wk-form4_1746747275.xml · nonDerivative · entry 1

Yanai Shlomo · CIK 0001562645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 285,985

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001628280-25-023993 · wk-form4_1746745423.xml · derivative · entry 2

Nark Ted C · CIK 0001316851 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 40,258 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

F2 · derivative.expiration_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

SEC source: 0001628280-25-023993 · wk-form4_1746745423.xml · nonDerivative · entry 1

Nark Ted C · CIK 0001316851 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 341,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001628280-25-023966 · wk-form4_1746742630.xml · derivative · entry 2

Patel Gautam · CIK 0001738054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 40,258 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

F2 · derivative.expiration_date: On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025.

SEC source: 0001628280-25-023966 · wk-form4_1746742630.xml · nonDerivative · entry 1

Patel Gautam · CIK 0001738054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,760,476

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001628280-25-022719 · wk-form4_1746563381.xml · nonDerivative · entry 1

Patel Gautam · CIK 0001738054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,725,118

F1 · price: These transactions occurred automatically pursuant to a plan adopted by the Reporting Person on August 15, 2024, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.01 per share, inclusive. The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

SEC source: 0001628280-25-016184 · wk-form4_1743624762.xml · nonDerivative · entry 1

Patel Gautam · CIK 0001738054 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,728,886

F1 · price: These transactions occurred automatically pursuant to a plan adopted by the Reporting Person on August 15, 2024, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.17 to $8.43 per share, inclusive. The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

SEC source: 0000898432-25-000191 · form4.xml · nonDerivative · entry 1

Patel Tushar Bhikhubhai · CIK 0001745375 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By a Limited Liability Company Controlled by a Family Trust

Disclosed balance after: 48,578,209

SEC source: 0001628280-25-012344 · wk-form4_1741810301.xml · nonDerivative · entry 1

BUCHI J KEVIN · CIK 0001209726 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: On March 10, 2025, reporting person gifted 262,072 shares of Class A Common Stock to a trust for no consideration. The Reporting person is trustee of the trust, and the son of the reporting person is the sole beneficiary.

F1 · ownership.direct: On March 10, 2025, reporting person gifted 262,072 shares of Class A Common Stock to a trust for no consideration. The Reporting person is trustee of the trust, and the son of the reporting person is the sole beneficiary.

SEC source: 0001628280-25-011306 · wk-form4_1741382266.xml · nonDerivative · entry 2

Daly Jason B. · CIK 0001906486 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,606

F2 · price: The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.64 to $8.84 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

SEC source: 0001628280-25-011300 · wk-form4_1741382194.xml · nonDerivative · entry 1

Alva Emily Peterson · CIK 0001738422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,771

F1 · price: The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.62 to $9.00 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

SEC source: 0001628280-25-011306 · wk-form4_1741382266.xml · nonDerivative · entry 1

Daly Jason B. · CIK 0001906486 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,542

F1 · price: The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.62 to $9.00 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

SEC source: 0001628280-25-011310 · wk-form4_1741382302.xml · nonDerivative · entry 1

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 290,106

F1 · price: The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.70 to $9.00 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

SEC source: 0001628280-25-011303 · wk-form4_1741382230.xml · nonDerivative · entry 1

Konidaris Tasos · CIK 0001320982 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 621,882

F1 · price: The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.84 to $8.98 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.

SEC source: 0001628280-25-010688 · wk-form4_1741221088.xml · derivative · entry 9

Patel Chintu · CIK 0001737428 · Director · Co-CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 277,778

Underlying: Class A Common Stock · 92,592 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F9 · derivative.exercise_date: On March 4, 2024, the Reporting Person was granted 370,370 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

F9 · derivative.expiration_date: On March 4, 2024, the Reporting Person was granted 370,370 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-25-010688 · wk-form4_1741221088.xml · nonDerivative · entry 4

Patel Chintu · CIK 0001737428 · Director · Co-CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 864,033

F5 · shares: Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

SEC source: 0001628280-25-010688 · wk-form4_1741221088.xml · nonDerivative · entry 3

Patel Chintu · CIK 0001737428 · Director · Co-CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 910,561

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issues was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5

F4 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001628280-25-010719 · wk-form4_1741224087.xml · derivative · entry 14

Daly Jason B. · CIK 0001906486 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,640

Underlying: Class A Common Stock · 35,879 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive on share of the Issuer's Class A Common Stock.

F11 · derivative.exercise_date: On March 4, 2024, the Reporting Person was granted 143,519 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

F11 · derivative.expiration_date: On March 4, 2024, the Reporting Person was granted 143,519 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-25-010719 · wk-form4_1741224087.xml · nonDerivative · entry 8

Daly Jason B. · CIK 0001906486 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,606

F3 · shares: Represents Shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.

SEC source: 0001628280-25-010719 · wk-form4_1741224087.xml · nonDerivative · entry 7

Daly Jason B. · CIK 0001906486 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,185

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.

F2 · price: Each restricted stock unit represents a contingent right to receive on share of the Issuer's Class A Common Stock.

SEC source: 0001628280-25-010718 · wk-form4_1741223923.xml · derivative · entry 14

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,582

Underlying: Class A Common Stock · 38,194 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F11 · derivative.exercise_date: On March 4, 2024, the Reporting Person was granted 152,778 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

F11 · derivative.expiration_date: On March 4, 2024, the Reporting Person was granted 152,778 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-25-010718 · wk-form4_1741223923.xml · nonDerivative · entry 8

BOYER ANDREW S · CIK 0001239546 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 415,106

F3 · shares: Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.